INDEarnings•globenewswire•
Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Sentiment:Positive (65)
Summary
Company Initiates Combination Trial and Strengthens Balance Sheet to Support Continued Clinical Progress Company Initiates Combination Trial and Strengthens Balance Sheet to Support Continued Clinical Progress
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 13, 2025 by globenewswire